Written by Admin | Nov 12, 2021 5:00:00 AM
Study Background
Significantly greater number of primary endpoint responders is detected in treated vs. placebo arms by AIM-NASH but not manual AIM-NASH detected dose-dependent treatment response in Ph2 study, in addition a statistically significant difference in proportion of subjects achieving endpoints. Harrison et al.